← 홈

Antibody

1,830개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-10 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,830개
AntibodystaleCTI BioPharmaPhase 3

fludarabine, rituximab, pixantrone (fludarabine, rituximab, pixantrone)

Non-Hodgkin's Lymphoma · Non-Hodgkin's Lymphoma

#Non-HodgkinsLymphoma#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleHenan Cancer HospitalPhase 2

trastuzumab (Herceptin, fruquintinib＋trastuzumab + XELOX)

Gastric Adenocarcinoma; Gastric (Stomach) Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPhase 2

fulzerasib; cetuximab N01 (fulzerasib; cetuximab N01)

Colorectal Cancer; KRAS G12C Mutant Advanced Solid Tumors · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPhase 2

gemcitabine + cetuximab (gemcitabine + cetuximab)

Time to Progression · Time to Progression

#TimetoProgression#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleSun Yat-sen UniversityPhase 2

gemcitabine, vinorelbine and doxorubicin liposome, with or without rituximab (gemcitabine, vinorelbine and doxorubicin liposome, with or without rituximab)

Lymphoma, Large B-Cell, Diffuse · Lymphoma, Large B-Cell, Diffuse

#LymphomaLargeB-CellDiffuse#Antibody#Phase2#항체#면역항체+5
임상시험 1상태 ACTIVE
AntibodystalePfizerPhase 3

gemtuzumab ozogamycin (gemtuzumab ozogamycin)

Acute Myeloid Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleArrys TherapeuticsPhase 2

pembrolizumab (Keytruda, grapiprant and pembrolizumab)

Non-small Cell Lung Cancer Adenocarcinoma · Non-small Cell Lung Cancer Adenocarcinom

#Non-smallCellLungCancerAdenocarc#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodyBiologicstaleGilead SciencesPhase 2

the doxorubicin conjugate of milatuzumab (hLL1-DOX, hLL1-DOX (the doxorubicin conjugate of milatuzumab))

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodyBiologicstaleSuZhou Stainwei Biotech Inc.Phase 1

hPV19 mAb (hPV19 mAb)

Solid Tumors · Solid Tumors

#SolidTumors#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleHawaii Pacific HealthPhase 2

ranibizumab (Lucentis, high-dose ranibizumab)

PCV; Polypoidal Choroidal Vasculopathy · PCV

#PCV#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleGruppo Italiano Malattie EMatol…Preclinical

idelalisib and rituximab (idelalisib and rituximab)

Chronic Lymphocytic Leukemia · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleUniversity Hospital, BordeauxPhase 3

immunomodulatory treatment by rituximab (immunomodulatory treatment by rituximab)

Mental Disorder · Mental Disorder

#MentalDisorder#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleTaipei Medical University WanFa…Approved

nivolumab (Opdivo, immunotherapy with Nivolumab)

Liver Cancer · Liver Cancer

#LiverCancer#Antibody#Approved#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRuijin HospitalPhase 2

pembrolizumab (Keytruda, immunotherapy：pembrolizumab；chemo：albumin-bound paclitaxel and cisplatin)

Locally Advanced Head and Neck Squamous Cell Carcinoma · Locally Advanced Head and Neck Squamous

#LocallyAdvancedHeadandNeckSquamo#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleSpectrum Pharmaceuticals, IncPhase 2

indium-111-ibritumomab tiuxetan (indium-111-ibritumomab tiuxetan)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleJanssenPreclinical

adalimumab (Humira, infliximab and adalimumab)

Crohn's Disease; Ulcerative Colitis · Crohn's Disease

#CrohnsDisease#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleJanssenPreclinical

infliximab and azathioprine combination at week 0 (infliximab and azathioprine combination at week 0)

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPreclinical

infliximab and azathioprine combination at week 14 (infliximab and azathioprine combination at week 14)

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenApproved

infliximab therapeutic drug monitoring (infliximab therapeutic drug monitoring)

Crohn Disease; Ulcerative Colitis · Crohn Disease

#CrohnDisease#Antibody#Approved#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleJanssenPreclinical

ustekinumab (Stelara, infliximab, adalimumab, golimumab, vedolizumab, ustekinumab)

Ulcerative Colitis · Ulcerative Colitis

#UlcerativeColitis#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE

86 / 92 페이지

← 이전다음 →